Seed round led by Norrsken22, with participation from Flourish Ventures, Twenty Two Ventures, Phosphor Capital and Y ...
Optune Lua is now approved for use concurrently with immune checkpoint inhibitors or docetaxel in adult patients with metastatic NSCLC who have progressed on or after a platinum-based regimen CE Mark ...
The first treatment of its kind for metastatic NSCLC, Optune Lua is approved for use concurrently with PD-1/PD-L1 inhibitors or docetaxel in adult patients with metastatic NSCLC who progressed on or ...
Roblox has exploded in popularity over the past few years, attracting millions of players and developers worldwide. With this ...
Optune Lua received a CE Mark for treating metastatic NSCLC, used with immune checkpoint inhibitors or docetaxel after progression on a platinum-based regimen. The phase 3 LUNAR trial showed ...
Seed round led by Norrsken22, with participation from Flourish Ventures, Twenty Two Ventures, Phosphor Capital and Y ...